[Morphofunctional characteristics of myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of angiotensin II].
V A
VA
Frolov
G A
GA
Drozdova
V F
VF
Mustiatsa
V V
VV
Balaev
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D006352:Heart Ventricles / Q000473:pathology; D006978:Hypertension, Renovascular / Q000150:complications / Q000473:pathology* / Q000503:physiopathology*; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology*; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011817:Rabbits; D013777:Tetrazoles / Q000494:pharmacology; D014633:Valine / Q000031:analogs & derivatives / Q000494:pharmacology; D000068756:Valsartan
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D013777:Tetrazoles; D000804:Angiotensin II; D000068756:Valsartan; D014633:Valine
Morfofunktsional'naia kharakteristika gipertrofii miokarda u krolikov s vazorenal'noĭ arterial'noĭ gipertenzieĭ pri farmakologicheskoĭ blokade deĭstviia angiotenzina II.